METEOR-1: A phase I study GSK3326595, a first-in-class protein arginine methyltransferase 5 (PRMT5) inhibitor, in advanced solid tumours Meeting Abstract
| Authors: | Siu, L. L.; Rasco, D. W.; Postel Vinay, S.; Martin Romano, P.; Menis, J.; Opdam, F. L.; Heinhuis, K. M.; Egger, J. L.; Gorman, S. A.; Parasrampuria, R.; Wang, K.; Kremer, B. E.; Gounder, M. M. |
| Abstract Title: | METEOR-1: A phase I study GSK3326595, a first-in-class protein arginine methyltransferase 5 (PRMT5) inhibitor, in advanced solid tumours |
| Meeting Title: | 44th ESMO Congress (ESMO 2019) |
| Journal Title: | Annals of Oncology |
| Volume: | 30 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2019 Sep 27-Oct 1 |
| Meeting Location: | Barcelona, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2019-10-01 |
| Start Page: | mdz244 |
| Language: | English |
| ACCESSION: | WOS:000491295501255 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdz244 |
| Notes: | Meeting Abstract: 438O -- Appears on page v159 of the abstract book -- Source: Wos |
